Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort.
Ivell R, Heng K, Severn K, Antonio L, Bartfai G, Casanueva FF, Huhtaniemi IT, Giwercman A, Maggi M, O'Connor DB, O'Neill TW, Punab M, Rastrelli G, Slowikowska-Hilczer J, Tournoy J, Vanderschueren D, Wu FCW, Anand-Ivell R. Ivell R, et al. Front Endocrinol (Lausanne). 2022 Nov 8;13:1016107. doi: 10.3389/fendo.2022.1016107. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36425465 Free PMC article.
Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men.
Abbara A, Koysombat K, Phylactou M, Eng PC, Clarke S, Comninos AN, Yang L, Izzi-Engbeaya C, Hanassab S, Smith N, Jayasena CN, Xu C, Quinton R, Pitteloud N, Binder G, Anand-Ivell R, Ivell R, Dhillo WS. Abbara A, et al. Among authors: ivell r. Front Endocrinol (Lausanne). 2022 Nov 29;13:1076984. doi: 10.3389/fendo.2022.1076984. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36523592 Free PMC article.
Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold.
Anand-Ivell R, Heng K, Antonio L, Bartfai G, Casanueva FF, Maggi M, O'Neill TW, Punab M, Rastrelli G, Slowikowska-Hilczer J, Tournoy J, Vanderschueren D, Wu FC, Huhtaniemi IT, Ivell R. Anand-Ivell R, et al. Among authors: ivell r. Aging Male. 2024 Dec;27(1):2346322. doi: 10.1080/13685538.2024.2346322. Epub 2024 Apr 26. Aging Male. 2024. PMID: 38676285 Review.
Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort.
Anand-Ivell R, Heng K, Severn K, Antonio L, Bartfai G, Casanueva FF, Huhtaniemi IT, Giwercman A, Maggi M, O'Neill TW, Punab M, Rastrelli G, Slowikowska-Hilczer J, Tournoy J, Vanderschueren D, Wu FCW, Ivell R. Anand-Ivell R, et al. Among authors: ivell r. Andrology. 2022 Oct;10(7):1328-1338. doi: 10.1111/andr.13220. Epub 2022 Jul 11. Andrology. 2022. PMID: 35770372 Free PMC article.
Expression and Role of INSL3 in the Fetal Testis.
Ivell R, Mamsen LS, Andersen CY, Anand-Ivell R. Ivell R, et al. Front Endocrinol (Lausanne). 2022 Apr 6;13:868313. doi: 10.3389/fendo.2022.868313. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35464060 Free PMC article. Review.
The Physiology of Reproduction - Quo vadis?
Ivell R, Anand-Ivell R. Ivell R, et al. Front Physiol. 2021 Mar 30;12:650550. doi: 10.3389/fphys.2021.650550. eCollection 2021. Front Physiol. 2021. PMID: 33859571 Free PMC article. Review.
261 results